Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 21, 2024 (Week 38) column labels (in same order that data fields appears in each record below): Reporting Area Carbapenemase-Producing Organisms (CPO), Total §; Current week Carbapenemase-Producing Organisms (CPO), Total §; Previous 52 weeks Max + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2024 + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2023 + tab delimited data: U.S. Residents, excluding U.S. Territories 37 NC 3,005 4,769 New England - NC 48 75 Connecticut - NC - - Maine - NC 10 36 Massachusetts - NC - - New Hampshire - NC 13 18 Rhode Island - NC 25 21 Vermont - NC - - Middle Atlantic 3 NC 112 403 New Jersey - NC - - New York (excluding New York City) - NC - - New York City - NC - 169 Pennsylvania 3 NC 112 234 East North Central 23 NC 1,503 1,894 Illinois - NC 14 536 Indiana - NC 211 285 Michigan 1 NC 131 241 Ohio 22 NC 1,029 801 Wisconsin - NC 118 31 West North Central - NC 104 198 Iowa - NC 44 69 Kansas - NC 56 66 Minnesota - NC - 54 Missouri - NC - - Nebraska - NC - - North Dakota - NC - 8 South Dakota - NC 4 1 South Atlantic 11 NC 407 613 Delaware - NC 15 12 District of Columbia - NC - - Florida N NC N N Georgia - NC - 233 Maryland - NC - - North Carolina - NC - 121 South Carolina - NC - - Virginia 11 NC 319 183 West Virginia - NC 73 64 East South Central - NC 60 156 Alabama N NC N N Kentucky - NC - - Mississippi - NC 60 156 Tennessee - NC - - West South Central - NC - 18 Arkansas - NC - - Louisiana - NC - 18 Oklahoma - NC - - Texas U NC U U Mountain - NC 754 731 Arizona - NC 710 592 Colorado - NC - - Idaho - NC - - Montana - NC 8 1 Nevada - NC 1 83 New Mexico - NC - - Utah - NC 35 54 Wyoming - NC - 1 Pacific - NC 17 681 Alaska - NC - - California - NC - 579 Hawaii - NC - 15 Oregon - NC 17 22 Washington - NC - 65 U.S. Territories - NC - 132 American Samoa - NC - - Commonwealth of Northern Mariana Islands - NC - - Guam - NC - - Puerto Rico - NC - 132 U.S. Virgin Islands - NC - - Non-U.S. Residents - NC 2 - Total 37 NC 3,007 4,901 U: Unavailable - The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases - The reporting jurisdiction did not submit any cases to CDC. N: Not reportable - The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable - This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated - There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. * Case counts for reporting years 2023 and 2024 are provisional and subject to change. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/ § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.